RANDOMIZED PHASE-II STUDY OF PIXY321 OR NEUPOGEN (RHUG-CSF) IN COMBINATION WITH DHAP AS SALVAGE THERAPY FOR LYMPHOMA

Authors
SCHUSTER MW BEVERIDGE RA SOSMAN JA MOLINA A LIEVSVELD JL BORSON R CARON D
Citation
Mw. Schuster et al., RANDOMIZED PHASE-II STUDY OF PIXY321 OR NEUPOGEN (RHUG-CSF) IN COMBINATION WITH DHAP AS SALVAGE THERAPY FOR LYMPHOMA, Blood, 86(10), 1995, pp. 204-204
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
86
Issue
10
Year of publication
1995
Supplement
1
Pages
204 - 204
Database
ISI
SICI code
0006-4971(1995)86:10<204:RPSOPO>2.0.ZU;2-A